<DOC>
	<DOCNO>NCT00078312</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability Armodafinil ( CEP-10953 ) administer flexible-dosage regimen 100 250 mg/day 12 month patient excessive sleepiness associate current diagnosis narcolepsy , obstructive sleep apnea/hypopnea syndrome ( OSAHS ) ( regular user nasal continuous positive airway pressure [ nCPAP ] therapy ) , chronic shift work sleep disorder ( SWSD ) .</brief_summary>
	<brief_title>Armodafinil ( CEP-10953 ) Treatment Narcolepsy , Obstructive Sleep Apnea/Hypopnea Syndrome , Chronic Shift Work Sleep Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Patients include study follow criterion meet : 1 . Written inform consent obtain . 2 . Men woman ( outpatient ) ethnic origin , 18 65 year age ( inclusive ) eligible . 3 . The patient complaint excessive sleepiness associate current diagnosis : NarcolepsyDiagnosis make basis International Classification Sleep Disorders ( ICSD ) ( American Sleep Disorders Association 2000 ) criterion . OSAHSDiagnosis make basis ICSD criterion . Furthermore , patient OSAHS must meet follow nCPAP therapy requirement : Previous adequate education intervention effort encourage nCPAP therapy use must document . A patient 's nCPAP therapy regimen must stable least 4 week . nCPAP therapy effective , opinion investigator . Evidence regular nCPAP usage must show 2 week evaluation period ( ie , nCPAP therapy usage least 4 hours/night least 70 % night ) . Chronic SWSDDiagnosis make basis least minimum ICSD criterion . Furthermore , patient chronic SWSD must excessive sleepiness night shift least 3 month , work minimum 3 night shift per month include least 6 hour 2200 0800 long 12 hour duration , plan continue work night shift throughout study . 4 . The patient Clinical Global Impression Severity Disease ( CGIS ) rating 4 . ( For patient OSAHS , CGIS scale administer nCPAP effectiveness regular usage establish . For patient narcolepsy OSAHS , CGIS evaluate assess general clinical condition . For patient SWSD , CGIS evaluate assess sleepiness night shift include commute work . ) 5 . The patient good health determine medical psychiatric history , medical examination , electrocardiogram ( ECG ) , serum chemistry hematology . Women must surgically sterile , 2 year postmenopausal , childbearing potential , must use medically accept method birth control ( ie , barrier method spermicide , steroidal contraceptive [ oral , implanted , DepoProvera contraceptives must use conjunction barrier method ] , intrauterine device [ IUD ] ) . 6 . The patient may prescribe PROVIGIL stimulant therapy treat sleep disorder ; however , must undergo washout period least 7 day prior screen assessment . 7 . The patient must willing able comply study restriction attend regularly schedule clinic visit specify protocol . Patients exclude participate study 1 follow criterion meet : 1. clinically significant , uncontrolled medical condition ( treat untreated ) 2. probable diagnosis current sleep disorder primary diagnosis narcolepsy , OSAHS , chronic SWSD 3. consume caffeine include coffee , tea and/or caffeine contain beverage food average 600 mg caffeine 8 cup coffee per day 4. use prescription drug disallow protocol clinically significant use overthecounter ( OTC ) drug within 7 day baseline visit 5. history alcohol , narcotic , drug abuse define Diagnostic Statistical Manual American Psychiatric Association , 4th Edition ( DSM IV ) 6. positive UDS screen visit 7. clinically significant deviation normal physical examination 8. pregnant lactating . Any woman become pregnant study withdrawn study 9. use investigational drug within 1 month screen visit 10. disorder may interfere drug absorption , distribution , metabolism , excretion ( include gastrointestinal surgery ) 11. know clinically significant drug sensitivity stimulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Excessive Sleepiness</keyword>
	<keyword>Narcolepsy</keyword>
	<keyword>Cataplexy</keyword>
	<keyword>Sleep Attacks</keyword>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Obstructive Sleep Hypopnea</keyword>
	<keyword>nCPAP</keyword>
	<keyword>Chronic Shift Work Sleep Disorder</keyword>
	<keyword>Chronic SWSD</keyword>
	<keyword>Circadian Rhythm Disorder</keyword>
	<keyword>Shift Worker</keyword>
	<keyword>Cepahlon</keyword>
	<keyword>Cephalon , Inc</keyword>
	<keyword>Nuvigil</keyword>
</DOC>